The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Basal cell carcinoma 21
Rituximab Fistula 21
RITUXIMAB Hyperparathyroidism primary 21
Rituximab Immunoglobulins decreased 21
RITUXIMAB Parathyroid tumour benign 21
Rituximab Spinal pain 21
Rituximab Foot fracture 20
Rituximab Leukopenia 20
Rituximab Meningioma 20
Rituximab Papillary thyroid cancer 20
RITUXIMAB Psoriasis 20
RITUXIMAB Viral load increased 20
Rituximab Vitamin D deficiency 20
Rituximab Arthritis bacterial 19
RITUXIMAB Condition aggravated 19
RITUXIMAB Decreased appetite 19
Rituximab Drug resistance 19
Rituximab Fall 19
Rituximab Renal failure 19
Rituximab Ear infection 18

Total Records: 1,104     Number of Pages: 56